Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clonal dynamics and copy number variants by single‐cell analysis in leukemic evolution of myeloproliferative neoplasms
Laura Calabresi, Chiara Carretta, Simone Romagnoli, et al.
American Journal of Hematology (2023) Vol. 98, Iss. 10, pp. 1520-1531
Open Access | Times Cited: 11

Showing 11 citing articles:

Treatment‐associated decline inJAK2V617F allele burden in polycythemia vera: What does it mean?
Ayalew Tefferi, Animesh Pardanani, Naseema Gangat
American Journal of Hematology (2024) Vol. 99, Iss. 8, pp. 1459-1461
Closed Access | Times Cited: 2
Synergistic effect of concurrent high molecular risk mutations and lower JAK2 mutant variant allele frequencies on prognosis in patients with myelofibrosis—insights from a multicenter study
Yu‐Hung Wang, Chao‐Hung Wei, Chien‐Chin Lin, et al.
Leukemia (2024)
Closed Access | Times Cited: 1
Myeloproliferative Neoplasms: Challenging Dogma
Jerry L. Spivak
Journal of Clinical Medicine (2024) Vol. 13, Iss. 22, pp. 6957-6957
Open Access | Times Cited: 1
Deciphering clonal architecture and evolutionary dynamics of secondary acute myeloid leukemia and donor‐derived myelodysplastic syndrome using single‐cell multi‐omics analysis
Meng‐Ta Sung, Lo‐Ho Chen, Ya‐Wen Chiang, et al.
American Journal of Hematology (2023) Vol. 98, Iss. 12
Open Access | Times Cited: 2
Risk models in myelofibrosis—the past, present, and future
Ayalew Tefferi, Alessandro M. Vannucchi
American Journal of Hematology (2024) Vol. 99, Iss. 4, pp. 519-522
Closed Access
Chromosome 9p trisomy increases stem cells clonogenic potential and fosters T-cell exhaustion in JAK2-mutant myeloproliferative neoplasms
Chiara Carretta, Sandra Parenti, Matteo Bertesi, et al.
Leukemia (2024) Vol. 38, Iss. 10, pp. 2171-2182
Open Access
Characterization of myeloproliferative neoplasms based on genetics only and prognostication of transformation to blast phase
Wencke Walter, Niroshan Nadarajah, Stephan Hütter, et al.
Leukemia (2024)
Open Access
Dominance of mutations in epigenetic regulators and a diversity of signaling alterations in blast‐phase BCR::ABL1‐negative myeloproliferative neoplasms
Petruta Gurban, Cristina Mambet, Anca Botezatu, et al.
American Journal of Hematology (2024)
Open Access
CALR mutations possess unique prognostic relevance in myelofibrosis—before and after transplant
Ayalew Tefferi, Alessandro M. Vannucchi
Bone Marrow Transplantation (2023) Vol. 59, Iss. 1, pp. 1-3
Open Access | Times Cited: 1
Molecular pathogenesis of myeloproliferative neoplasms: Where do we stand in 2023?
Violaine Havelange, Stefan N. Constantinescu
American Journal of Hematology (2023) Vol. 98, Iss. 10, pp. 1512-1516
Open Access | Times Cited: 1
Characterization of myeloproliferative neoplasms based on genetics only and prognostication of transformation to blast phase
Manja Meggendorfer, Wencke Walter, Niroshan Nadarajah, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top